Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients.
BACKGROUND
The aim of this study was to assess clinical outcome after laparoscopic treatment of borderline ovarian tumor (BOT).


METHODS
Thirty-four patients treated initially and/or for recurrent disease using a laparoscopic approach for BOT from 1984 to January 2002.


RESULTS
Thirty-four patients underwent laparoscopic pure treatment (without conversion by laparotomy and/or reassessment surgery by laparotomy) for BOT. Conservative treatment was performed in 31 (91%) patients. Median follow-up time was 45 months (range 6-228). Six (17%) patients recurred (in the remaining ovary following conservative surgery in five patients and in the peritoneum in one patient). Two port-site metastases were observed. None of the patients had recurrent disease in the form of ovarian carcinoma. Nine spontaneous pregnancies were observed in six patients from a group of 15 patients desiring pregnancy. All patients are alive today and disease-free.


CONCLUSIONS
These results seem to demonstrate that laparoscopic treatment can be safely performed in young patients with early stage BOT. Such a procedure is then feasible, but should be evaluated in patients with BOT and peritoneal implants.
Camatte
S
S
Institut Gustave Roussy, Villejuif, France.
Morice
P
P
Atallah
D
D
Thoury
A
A
Pautier
P
P
Lhommé
C
C
Duvillard
P
P
Castaigne
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010535:Laparoscopy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000601:surgery*; D010053:Ovary / Q000503:physiopathology / Q000601:surgery; D016896:Treatment Outcome